Adamis Viral Therapeutics Inc

Pacira Pharmaceuticals, based in San Diego, CA, is a leader in transforming pain management through innovative non-opioid therapies designed to address chronic postsurgical and musculoskeletal pain. Committed to safety and efficacy, the company actively researches advanced treatments, including promising gene therapy solutions aimed at improving patient outcomes. The organization emphasizes education and advocacy to expand access to non-opioid pain management options, ensuring patients experience meaningful relief while promoting faster recovery. With a passionate team dedicated to excellence, Pacira fosters an environment where employees can contribute to impactful advancements in patient care. Generated from the website

Imprimis Pharmaceuticals, a subsidiary of Harrow Inc., is dedicated to providing high-quality compounded medications and FDA-approved formulations tailored for unique patient and practitioner needs. Operating from both a patient-specific 503A pharmacy and an FDA-Registered Outsourcing Facility, the company emphasizes accessibility and affordability in sight-saving medications for patients. With a commitment to evolving beyond traditional compounding, ImprimisRx partners with leading ophthalmologists and optometrists to ensure that critical medications are available at accessible prices. The company prioritizes quality standards while working to enhance its product offerings for the benefit of healthcare providers and their patients. Generated from the website

ARS Pharmaceuticals, Inc., based in San Diego, CA, is dedicated to developing innovative, patient-friendly treatments that address the serious risks associated with needle use. Their flagship product, neffy, is the first and only FDA-approved needle-free epinephrine nasal spray, designed for ease of use and portability for patients and caregivers. Committed to making the latest treatment options affordable, ARS Pharma offers co-pay support and patient assistance programs for those who qualify. The company emphasizes the importance of providing alternative options for epinephrine delivery, enhancing accessibility and reducing the fear associated with traditional injection methods. Generated from the website